Related Experiment Videos
Modelling of multiple sclerosis: lessons learned in a non-human primate
Bert A 't Hart1, Jon D Laman, Jan Bauer
1Department of Immunobiology, Biomedical Primate Research Centre, Rijswijk, Netherlands. hart@bprc.nl
The Lancet. Neurology
|September 24, 2004
Summary
Researchers present a non-human primate model, the common marmoset, for studying chronic multiple sclerosis (MS). This model offers a more immunologically relevant preclinical platform for developing novel MS therapies.
Area of Science:
- Immunology
- Neuroscience
- Primate Models
Background:
- Developing effective biological therapies for immune-based diseases requires valid preclinical models.
- Existing mouse and rat models present significant immunological differences from humans, limiting their translatability.
- A need exists for animal models that better mimic human immune responses and disease pathology.
Purpose of the Study:
- To introduce and validate a non-human primate model for chronic multiple sclerosis (MS).
- To establish experimental autoimmune encephalitis (EAE) in the common marmoset (Callithrix jacchus) as a relevant preclinical model for MS research.
- To leverage the genetic and immunological similarities between marmosets and humans for improved MS research.
Main Methods:
- Induction of experimental autoimmune encephalitis (EAE) in the common marmoset (Callithrix jacchus).
- Characterization of clinical and neuropathological features of the induced EAE model.
- Assessment of genetic and immunological parallels between marmosets and humans relevant to MS.
Main Results:
- The common marmoset EAE model exhibits clinical and neuropathological similarities to human MS.
- Marmosets share significant genetic and immunological characteristics with humans, bridging the gap seen in rodent models.
- This model provides a viable platform for investigating MS immunopathogenesis.
Conclusions:
- The common marmoset EAE model serves as a valuable preclinical tool for multiple sclerosis (MS) research.
- Its immunological relevance offers a unique advantage for studying disease mechanisms and testing new therapies.
- This primate model facilitates the development of more effective treatments for MS by better reflecting human disease.